EHA-LSHBT Hematology Update on Anticoagulation & AML
EHA and the Lebanese Society of Hematology and Blood Transfusion (LSHBT) invite you to the third webinar of the Hematology Updates course.
This 2,5 hour workshop focussed on anticoagulation & AML and through keynote presentations and patient cases treatment strategies were discussed. Participants could join and submit all their questions to the faculty of the workshop in the Q&A panel discussions.
Live session date: May 6, 2021
Live session time: 17:00 – 19:30 EEST*
Chairs: G Gaidano (IT), A Taher (LB)
*The program is scheduled in EET (Eastern European Time). Please check carefully what time this is for you.
Target audience
The main target audience is hematologists in North Africa & Middle East, but the course is open to attend for all.
Program
- Opening & Welcome
- Session 1: Anticoagulation
- Case Presentation: Patient with High Thrombophilic Risk: Is there one correct answer? - F Kreidieh (LB)
- Keynote Presentation: Recent advances in anticoagulation: From prophylaxis to treatment
S Temraz (LB) - Q&A Panel Discussion
- Session 2: AML
- Case Presentation: Title and speaker to be announced
- Keynote Presentation: Target therapy in acute myeloid leukemia
G Ossenkoppele (NL) - Q&A Panel Discussion
- Closing Remarks
Cancellation of registration
Should you wish to cancel your registration then please contact tutorials@ehaweb.org.
EBAH-CME
Continuing Medical Education (CME) is widely accepted to encourage individual practitioners to maintain and develop professional knowledge and skills keeping up-to-date with latest developments within the field.
The EHA-LSHBT Virtual Hematology Updates are accredited by the EBAH system. Participants who join the live webinars of the EHA-LSHBT Virtual Hematology Series are eligible to receive 2.5 CME credit points per course. Participants who watch the on-demand recording of the webinar are eligible to receive one (1) CME point.
Back